Navigation Links
George Golumbeski, President of GRAIL, Inc. to Deliver Keynote at BD Boston 2018
Date:7/26/2018

Boston Biotech Conferences will host BD Boston, an invitation-only, off-the-record meeting for C-level biopharma executives on September 4, 2018 at The Hilton Boston Back Bay Hotel. This peer-to-peer meeting provides an opportunity for industry leaders to leverage insight from real-life business development experiences and dissect the most relevant deals in biotech.

George Golumbeski recently joined GRAIL with more than 25 years of experience in the biotechnology industry. He currently serves on the Board of Directors at KSQ Therapeutics, Carrick Therapeutics, Enanta Pharmaceuticals, and MorphoSys. Dr. Golumbeski was most recently Executive Vice President of Business Development for Celgene, where he was responsible for forging collaborations with biotechnology companies seeking to bring breakthrough medications to people suffering from cancer and chronic inflammation.

To attend, please register here.

ABOUT BOSTON BIOTECH CONFERENCES:
Boston Biotech Conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community. These meetings convene the most relevant players in biotech to network, forge partnerships and leverage the experiences of their peers in an off-the-record setting. For more information, please visit: http://www.bostonbiotechconferences.com

Contact:
Boston Biotech Conferences
Suzanne Carroll: suzanne@bbbiotechconference.com
Nicole Hayes: nicole@bbbiotechconference.com

Read the full story at https://www.prweb.com/releases/george_golumbeski_president_of_grail_inc_to_deliver_keynote_at_bd_boston_2018/prweb15648780.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. The American Society for Microbiology honors George L. Drusano
2. Stephen Zarrilli Named President & CEO of University City Science Center
3. How to Fix President Trumps "Travel Ban" Executive Order; a 9/11 Commission Counsels Perspective
4. Texas Biomed Names Larry Schlesinger, M.D. As President/CEO
5. Genpact Executive Jeff Schultz Joins QStride As Vice President of National Business Development
6. Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer
7. American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect
8. EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables
9. Colombian president honors WCS president and CEO Dr. Cristián Samper
10. NXT-ID, Inc. Names Vice-President and Chief Financial Officer
11. JAX President and CEO Edison Liu, M.D., to receive Chen Award from HUGO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2019)... ... August 14, 2019 , ... Representatives with MyBioGate announced that ... Center in Boston. , “We help innovative projects connect with Chinese pharma and investors ... , Guo went on to explain that as a part of Biotech Week Boston ...
(Date:8/14/2019)... ... August 13, 2019 , ... ... of Molecular Pathology, Institute of Cancer Research (ICR) in a live webinar ... about the process of biomarker and companion diagnostic development including machine learning approaches ...
(Date:8/9/2019)... , ... August 09, 2019 , ... With a demand ... more and more patients will visit urgent care centers (UCC) in the coming years, ... The report, The Market for Urgent Care Centers , is a detailed look ...
Breaking Biology News(10 mins):
(Date:7/26/2019)... ... July 25, 2019 , ... LeadingBiotech , an ... today announces its Boston BD conference to be held on September ... Week Boston , the event provides an opportunity for attendees to leverage insight ...
(Date:7/19/2019)... ... July 18, 2019 , ... Global precision ... enlarge their current piezo motion facilities in Lederhose, Germany, increasing their current footprint ... piezo ceramic assembly production in addition to general office space, a significant increase ...
(Date:7/17/2019)... (PRWEB) , ... July 15, 2019 , ... CRISPR is ... that a certain trait can be removed, replaced, or edited, but Yiping Qi, assistant ... far beyond these traditional applications in his latest publication in Nature Plants. In this ...
(Date:7/17/2019)... ... July 16, 2019 , ... Quidel is the market ... Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also are among the ... Market for Point-of-Care (POC) Diagnostics . , Quidel is a market leader in ...
Breaking Biology Technology: